
Okyo Pharma
(NASDAQ) OKYO
Okyo Pharma Financials at a Glance
Market Cap
$85.27M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.30M
EPS (TTM)
$-0.13
P/E Ratio
-13.24
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$1.62
Volume
1,507
Open
$1.67
Price
$1.62
Volume
1,507
Open
$1.67
Previous Close
$1.66
Daily Range
$1.61 - $1.67
52-Week Range
$1.03 - $3.35
Dividend
$0.00
Beta (Volatility)
0.73 (Low)
Price
$1.62
Volume
1,507
Open
$1.67
Previous Close
$1.66
Daily Range
$1.61 - $1.67
52-Week Range
$1.03 - $3.35
OKYO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Okyo Pharma
Industry
Biotechnology
Sector
Health CareCEO
Gary S. Jacob, PhD
Website
www.okyopharma.comHeadquarters
London, W1K 1NA, GB
OKYO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
2%
Return on Assets
-99%
Earnings Yield
-7.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$85.27M
Shares Outstanding
51.37M
Volume
1.51K
Short Interest
0.00%
Avg. Volume
266.65K
Financials (TTM)
Gross Profit
$2.56K
Operating Income
$7.19M
EBITDA
$7.08M
Operating Cash Flow
$1.81M
Capital Expenditure
$1.21K
Free Cash Flow
$1.81M
Cash & ST Invst.
$1.56M
Total Debt
$0.00
Okyo Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$885.00
+78.6%
Gross Margin
0.00%
N/A
Market Cap
$85.27M
N/A
Market Cap/Employee
$28.42M
N/A
Employees
3
N/A
Net Income
$2.59M
-29238.2%
EBITDA
$2.50M
-28544.1%
Quarterly Fundamentals
Net Cash
$4.03M
-0.3%
Accounts Receivable
$23.41K
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$185.79K
N/A
Return on Assets
-99.34%
N/A
Return on Invested Capital
2.04%
N/A
Free Cash Flow
$1.53M
-22400.1%
Operating Cash Flow
$1.53M
-22400.0%